Supplementary Table 2. Comparative Vaccine Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines Among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021

Details

• Alternative Title:
  Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, U.S. February 1–September 30, 2021: Supplementary Table 2. Comparative Vaccine Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines Among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Subjects:
  Disease Notification Public Health Public Health Surveillance
• Source:
  MMWR: Morbidity and Mortality Weekly Report 2021; v. 70, no. 49
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Document Type:
  e-book
• Place as Subject:
  United States
• Pages in Document:
  1 pdf page
• Volume:
  70
• Issue:
  49
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:08c1a3de4a36be43e36b8f940bec6e90b08712a0a198f761df3dc7aa682e5e9692ab30cc0ab4e7b8edacb625854cb090bd6c19981fadc5d43c63d22182c52820
• Download URL:
  https://stacks.cdc.gov/view/cdc/112104/cdc_112104_DS1.pdf
• File Type:
  [PDF - 166.27 KB ]